MICROANEURYSM FORMATION RATE AS A PREDICTIVE MARKER FOR PROGRESSION TO CLINICALLY SIGNIFICANT MACULAR EDEMA IN NONPROLIFERATIVE DIABETIC RETINOPATHY

被引:53
|
作者
Haritoglou, Christos [1 ]
Kernt, Marcus [1 ]
Neubauer, Aljoscha [1 ]
Gerss, Joachim [2 ]
Oliveira, Carlos Manta [3 ]
Kampik, Anselm [1 ]
Ulbig, Michael [1 ]
机构
[1] Univ Munich, Dept Ophthalmol, D-80336 Munich, Germany
[2] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany
[3] Crit Hlth SA, Coimbra, Portugal
关键词
diabetic macular edema; progression; microaneurysm turnover; TURNOVER;
D O I
10.1097/IAE.0b013e318295f6de
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the predictive value of microaneurysm (MA) formation rate concerning the development of clinically significant macular edema (CSME) in patients with mild-to-moderate nonproliferative diabetic retinopathy as evaluated by an automated analysis of central field fundus 30 degrees photographs. Methods: Two hundred and eighty-seven eyes were included in the study. Photographs obtained at Day 0, at 6, and 12 months were analyzed using the RetmarkerDR software (Critical Health SA) in a masked manner, and the MA formation rate was documented. A threshold of a calculated MA formation rate of 2 or more was chosen to consider a patient "positive." The ability to predict CSME development was then calculated for a period of up to 5 years. HbA1c values, blood pressure, or duration of diabetes were also evaluated. Results: The study population consisted of 89 male and 59 female patients with a mean age of 57.6 years, a mean HbA1c of 7.8, and a mean duration of diabetes of 12.3 years. Forty-seven of 287 eyes (16.4%) developed CSME during follow-up. An increased MA formation rate of > 2 MA was clearly associated with development of CSME. Using the automated analysis and a threshold of 2 or more new MA, the authors were able to identify 70.2% of the eyes that developed CSME during follow-up ("true positive") and using a threshold of up to 2 new MA, 71.7% of the patients that did not develop CSME ("true negative"). No significant differences concerning baseline and 1-year HbA1c levels within patient eyes that developed CSME compared with patient eyes below or over the calculated threshold of 2 MA (P = 0.554 and P = 0.890, respectively) were seen. The positive and negative predictive value was calculated to be 33% versus 92.5%, sensitivity was 70%, and specificity was 72%. Conclusion: Using the RetmarkerDR software, the authors were able to identify patients with higher risk to develop CSME during follow-up using a threshold of 2 or more MA formation rate. Together with the high negative predictive value, the automated analysis may help to determine the individual risk of a patient to develop sight-threatening complications related to diabetic retinopathy and schedule individual screening intervals.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [31] Patterns of retinopathy progression in a five-year follow-up of mild nonproliferative retinopathy in diabetes type 2: Development of clinically signigicant macular edema
    Azevedo, H
    Duarte, L
    Nunes, S
    Bernardes, R
    Lobo, C
    Figueira, J
    Cunha-Vaz, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [32] Widefield OCT Angiography Biomarkers for Predicting Clinically Significant Outcomes in Eyes with Nonproliferative Diabetic Retinopathy
    Ding, Xinyi
    Romano, Francesco
    Garg, Itika
    Gan, Jenny
    Millner, Katherine Overbey
    Garcia, Mauricio De Jesus
    Vingopoulos, Filippos
    Bennett, Cade Frederick
    Rodriguez, Jocelyn
    Finn, Matthew
    Razavi, Peyman
    Vavvas, Demetrios G.
    Husain, Deeba
    Patel, Nimesh Arvind
    Miller, Joan W.
    Miller, John B.
    Ding, Xinyi
    Romano, Francesco
    Garg, Itika
    Gan, Jenny
    Millner, Katherine Overbey
    Garcia, Mauricio De Jesus
    Vingopoulos, Filippos
    Bennett, Cade Frederick
    Rodriguez, Jocelyn
    Finn, Matthew
    Razavi, Peyman
    Vavvas, Demetrios G.
    Husain, Deeba
    Patel, Nimesh Arvind
    Miller, Joan W.
    Miller, John B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [33] Tomographic assessment of laser photocoagulation for clinically significant diabetic macular edema
    Polito, A
    Del Borrello, M
    Zemella, N
    Bandello, F
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U426 - U426
  • [34] Impact of ocular hypotensive lipids on clinically significant diabetic macular edema
    Patel, Anu S.
    Patel, Chirag C.
    Goyal, Anju
    Anchala, Anupama
    Adrean, Sean
    Hughes, Bret
    Mahmoud, Tamer H.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2012, 22 (05) : 709 - 713
  • [35] Contrast sensitivity in treatment control of clinically significant diabetic macular edema
    Roldan-Pallares, M
    El Bromboly, TH
    ANNALS OF OPHTHALMOLOGY & GLAUCOMA, 1997, 29 (06): : 357 - 361
  • [36] Selective retina therapy (SRT) for clinically significant diabetic macular edema
    Johann Roider
    Shiao Hui Melissa Liew
    Carsten Klatt
    Hanno Elsner
    Erk Poerksen
    Jost Hillenkamp
    Ralf Brinkmann
    Reginald Birngruber
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 1263 - 1272
  • [37] Retreatment of Clinically Significant Diabetic Macular Edema: Effect on visual field
    RoldanPallares, M
    ElBromboly, TH
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 3544 - 3544
  • [38] Selective retina therapy (SRT) for clinically significant diabetic macular edema
    Roider, Johann
    Liew, Shiao Hui Melissa
    Klatt, Carsten
    Elsner, Hanno
    Poerksen, Erk
    Hillenkamp, Jost
    Brinkmann, Ralf
    Birngruber, Reginald
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (09) : 1263 - 1272
  • [39] REPEATED INTRAVITREAL INJECTION OF BEVACIZUMAB FOR CLINICALLY SIGNIFICANT DIABETIC MACULAR EDEMA
    Roh, Mi In
    Byeon, Suk Ho
    Kwon, Oh Woong
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (09): : 1314 - 1318
  • [40] CONTRAST SENSITIVITY IN TREATMENT CONTROL OF CLINICALLY SIGNIFICANT DIABETIC MACULAR EDEMA
    ROLDANPALLARES, M
    ELBROMBOLY, TH
    VILARMASEDA, NF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1593 - 1593